Effect of Lung Cancer Fang No.1 on Immune Function and Serum VEGF,CYFRA21-1 in Advanced Non-Small Cell Lung Cancer Patients
- VernacularTitle:肺癌1号方对晚期非小细胞肺癌患者免疫功能及血清VEGF、CYFRA21-1的影响
- Author:
Jianguo XIE
;
Qijuan YANG
;
Fenghua HE
- Publication Type:Journal Article
- Keywords:
Lung Cancer Fang No.1;
non-small cell lung cancer;
VEGF;
CYFRA21-1;
immune function
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2006;0(11):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the recent effect and influence of Lung Cancer Fang No.1 on immunologic function and serum vessel endothelia growth factor (VEGF), keratoprotein 21-1 (CYFRA21-1) in non-small cell lung cancer patients (NSCLC). Methods One hundred non-small cell lung cancer patients were randomized into 52 cases of treatment group on Lung Cancer Fang No.1 and 48 cases of chemotherapy group. The treatment group was treated by Lung Cancer Fang No.1, and the chemotherapy group by GP or TP programme for 2 treatment courses. Immune function indexes, serum VEGF and CYFRA21-1 were determined before and after treatment. Results Efficacy for the treatment group recently was 76.92%, better than 43.75% of the chemotherapy group (P
